As on January 13, 2021, Five Prime Therapeutics Inc. (NASDAQ: FPRX) started slowly as it slid -8.61% to $14.96. During the day, the stock rose to $16.34 and sunk to $14.50 before settling in for the price of $16.37 at the close. Taking a more long-term approach, FPRX posted a 52-week range of $1.75-$24.70.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -5.00%. Meanwhile, its Annual Earning per share during the time was -16.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 5.10%. This publicly-traded company’s shares outstanding now amounts to $46.32 million, simultaneously with a float of $36.10 million. The organization now has a market capitalization sitting at $625.48 million. At the time of writing, stock’s 50-day Moving Average stood at $16.34, while the 200-day Moving Average is $7.61.
While finding the extent of efficiency of the company that is accounted for 87 employees. It has generated 170,966 per worker during the last fiscal year. Meanwhile, its income per employee was -1,577,034. The stock had 3.24 Receivables turnover and 0.05 Total Asset turnover. For the Profitability, stocks operating margin was -909.80 and Pretax Margin of -922.43.
Five Prime Therapeutics Inc. (FPRX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Five Prime Therapeutics Inc.’s current insider ownership accounts for 0.80%, in contrast to 47.30% institutional ownership. According to the most recent insider trade that took place on Nov 11, this organization’s See Explanaton of Responses sold 7,393,340 shares at the rate of 20.19, making the entire transaction reach 149,247,137 in total value, affecting insider ownership by 81,263. Preceding that transaction, on Nov 11, Company’s Director sold 78,959 for 22.50, making the whole transaction’s value amount to 1,776,578. This particular insider is now the holder of 10,000 in total.
Five Prime Therapeutics Inc. (FPRX) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 9/29/2020, the company posted -$0.74 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.6) by -$0.14. This company achieved a net margin of -922.43 while generating a return on equity of -66.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
Five Prime Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 5.10% and is forecasted to reach -2.08 in the upcoming year.
Five Prime Therapeutics Inc. (NASDAQ: FPRX) Trading Performance Indicators
Let’s observe the current performance indicators for Five Prime Therapeutics Inc. (FPRX). It’s Quick Ratio in the last reported quarter now stands at 5.30. The Stock has managed to achieve an average true range (ATR) of 1.39. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 36.58.
In the same vein, FPRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.68, a figure that is expected to reach -0.53 in the next quarter, and analysts are predicting that it will be -2.08 at the market close of one year from today.
Technical Analysis of Five Prime Therapeutics Inc. (FPRX)
Through scrutinizing the latest numbers posted by the [Five Prime Therapeutics Inc., FPRX], it can be observed that its last 5-days Average volume of 0.73 million was better the volume of 0.69 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 27.18% While, its Average True Range was 1.43.
Raw Stochastic average of Five Prime Therapeutics Inc. (FPRX) in the period of the previous 100 days is set at 53.76%, which indicates a major rise in contrast to 8.12% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 68.54% that was lower than 218.04% volatility it exhibited in the past 100-days period.